Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Petrone

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 19, 2026
Impact of diabetes on TB infection diagnosisLinda Petrone, Alessandra Aiello, Saeid Najafi-Fard, et al.
Pathogens (Basel, Switzerland)|July 29, 2023
The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing PandemicLinda Petrone, Alessandro Sette, Rory D de Vries, et al.
Expert Opinion on Drug Safety|May 9, 2019
Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practiceFabrizio Cantini, Laura Niccoli, Alessandro Capone, et al.
Expert Opinion on Drug Safety|June 20, 2020
Systematic review on tuberculosis risk in patients with rheumatoid arthritis receiving inhibitors of Janus KinasesFabrizio Cantini, Corrado Blandizzi, Laura Niccoli, et al.
Expert Review of Anti-Infective Therapy|June 1, 2018
Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugsDelia Goletti, Linda Petrone, Giuseppe Ippolito, et al.
Mediators of Inflammation|June 30, 2017
Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted BiologicsFabrizio Cantini, Carlotta Nannini, Laura Niccoli, et al.
Drugs|October 17, 2020
Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic ReviewFabrizio Cantini, Delia Goletti, Linda Petrone, et al.
The Journal of Infection|September 2, 2019
QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysisGiovanni Sotgiu, Laura Saderi, Elisa Petruccioli, et al.
Breathe (Sheffield, England)|January 17, 2022
The definition of tuberculosis infection based on the spectrum of tuberculosis diseaseGiovanni Battista Migliori, Catherine W M Ong, Linda Petrone, et al.
The Journal of Infection|March 7, 2013
IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosisElisa Petruccioli, Linda Petrone, Valentina Vanini, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 19, 2026
Impact of diabetes on TB infection diagnosisLinda Petrone, Alessandra Aiello, Saeid Najafi-Fard, et al.
Pathogens (Basel, Switzerland)|July 29, 2023
The Importance of Measuring SARS-CoV-2-Specific T-Cell Responses in an Ongoing PandemicLinda Petrone, Alessandro Sette, Rory D de Vries, et al.
Expert Opinion on Drug Safety|May 9, 2019
Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practiceFabrizio Cantini, Laura Niccoli, Alessandro Capone, et al.
Expert Opinion on Drug Safety|June 20, 2020
Systematic review on tuberculosis risk in patients with rheumatoid arthritis receiving inhibitors of Janus KinasesFabrizio Cantini, Corrado Blandizzi, Laura Niccoli, et al.
Expert Review of Anti-Infective Therapy|June 1, 2018
Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugsDelia Goletti, Linda Petrone, Giuseppe Ippolito, et al.
Mediators of Inflammation|June 30, 2017
Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted BiologicsFabrizio Cantini, Carlotta Nannini, Laura Niccoli, et al.
Drugs|October 17, 2020
Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic ReviewFabrizio Cantini, Delia Goletti, Linda Petrone, et al.
The Journal of Infection|September 2, 2019
QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysisGiovanni Sotgiu, Laura Saderi, Elisa Petruccioli, et al.
Breathe (Sheffield, England)|January 17, 2022
The definition of tuberculosis infection based on the spectrum of tuberculosis diseaseGiovanni Battista Migliori, Catherine W M Ong, Linda Petrone, et al.
The Journal of Infection|March 7, 2013
IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosisElisa Petruccioli, Linda Petrone, Valentina Vanini, et al.
Pageof 8